SMAD3 and diabetic kidney disease: In DKD, miR-155 activates the TGF-β/Smad3 pathway, promoting the accumulation of ECM proteins such as collagen and fibronectin, which contributes to the progression of fibrosis and glomerulosclerosis [19].